MGMT-未甲基化胶质母细胞瘤的临床试验
总计1679个结果
-
Grupo Español de Investigación en NeurooncologíaPfizer完全的
-
Tracon Pharmaceuticals Inc.The Cleveland Clinic; Case Comprehensive Cancer Center完全的
-
Ohio State University Comprehensive Cancer Center完全的
-
National Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Emory UniversityNational Cancer Institute (NCI); Verastem, Inc.招聘中
-
Bristol-Myers Squibb主动,不招人复发性胶质母细胞瘤波兰, 英国, 美国, 西班牙, 澳大利亚, 德国, 意大利, 丹麦, 比利时, 法国, 荷兰, 瑞士
-
University of Wisconsin, MadisonNational Institute for Biomedical Imaging and Bioengineering (NIBIB)终止
-
Vascular Biogenics Ltd. operating as VBL Therapeutics完全的
-
Safe Save Medical Cell Sciences & Technology Co...未知
-
University of CincinnatiEisai Inc.撤销
-
Patrick Y. Wen, MDMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Dana-Farber Cancer Institute 和其他合作者完全的
-
Duke UniversityGenentech, Inc.; Eisai Inc.终止
-
Beijing Sanbo Brain HospitalMarino Biotechnology Co., Ltd.未知
-
Emory UniversityGenentech, Inc.; Millennium Pharmaceuticals, Inc.; Schering-Plough完全的
-
Northwest Biotherapeutics可用的
-
M.D. Anderson Cancer CenterCelgene Corporation完全的
-
Rigshospitalet, DenmarkWyeth is now a wholly owned subsidiary of Pfizer; University of Copenhagen; Roche, Copenhagen完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)完全的
-
Samus Therapeutics, Inc.终止复发性多形性胶质母细胞瘤 (GBM) | 3 级异柠檬酸脱氢酶 (IDH) 野生型星形细胞瘤 | 3 级或 4 级星形细胞瘤 | 胶质母细胞瘤手术美国
-
Washington University School of MedicineNational Institute of Neurological Disorders and Stroke (NINDS)完全的
-
Manmeet Ahluwalia, MDNational Cancer Institute (NCI); Novartis完全的
-
National Cancer Institute (NCI)终止